Phase 2b Controlled Study
NCT07140380 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-03-27
Summary
Double-masked two period controlled trial of three eyelid wipe dosing techniques
Conditions
Interventions
- DRUG
-
IVW-1001 Ophthalmic Eyelid Wipe
Dry eye treatment
Sponsors & Collaborators
-
IVIEW Therapeutics Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-20
- Primary Completion
- 2025-10-08
- Completion
- 2025-10-08
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
NCT05586152 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
NCT06370039 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
NCT01733992 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2
-
Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis
NCT05636228 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
NCT05865457 ·Status: RECRUITING ·Phase: NA
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Phase 3 Study of EBI-005 in Dry Eye Disease
NCT01998802 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis
NCT03749317 ·Status: COMPLETED ·Phase: PHASE2
-
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT00135824 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Assess Subjects With Dry Eye Disease.
NCT04971031 ·Status: COMPLETED ·Phase: PHASE2
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients
NCT01250171 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
NCT05661851 ·Status: COMPLETED ·Phase: PHASE2
-
Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
NCT03925727 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
NCT00037661 ·Status: COMPLETED ·Phase: PHASE3
-
Study of EBI-005 in Dry Eye Disease (DED)
NCT02405039 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00403715 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA